BARICITINIB

3052 reported adverse events

Drug classes: Janus Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking BARICITINIB:

# Side effect Count
0 OFF LABEL USE 462
1 DRUG INEFFECTIVE 349
2 COVID-19 180
3 RHEUMATOID ARTHRITIS 178
4 PULMONARY EMBOLISM 166
5 PNEUMONIA 142
6 CONDITION AGGRAVATED 125
7 DEEP VEIN THROMBOSIS 119
8 DEATH 102
9 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 86
See all common reactions for BARICITINIB

BARICITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMOGLOBIN C DISEASE 3 0.7500
1 ACINIC CELL CARCINOMA OF SALIVARY GLAND 5 0.5000
2 LUMBOSACRAL PLEXOPATHY 26 0.3023
3 MITRAL PERFORATION 4 0.2500
4 PERINEAL RASH 25 0.2033
5 STAPHYLOCOCCAL PAROTITIS 2 0.1818
6 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 8 0.1455
7 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 7 0.1167
8 NEUROLYSIS 3 0.0909
9 CUTANEOUS T-CELL LYMPHOMA STAGE IV 3 0.0833
See all enriched reactions for BARICITINIB